{"id":804800,"date":"2026-04-27T15:22:02","date_gmt":"2026-04-27T15:22:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=804800"},"modified":"2026-04-27T15:22:02","modified_gmt":"2026-04-27T15:22:02","slug":"epigenetics-market-to-reach-429-billion-by-2030-fueled-by-precision-medicine-and-nextgen-sequencing-advancements","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/epigenetics-market-to-reach-429-billion-by-2030-fueled-by-precision-medicine-and-nextgen-sequencing-advancements_804800.html","title":{"rendered":"Epigenetics Market to Reach $4.29 Billion by 2030, Fueled by Precision Medicine and Next-Gen Sequencing Advancements"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1777282091.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Epigenetics Market to Reach $4.29 Billion by 2030, Fueled by Precision Medicine and Next-Gen Sequencing Advancements\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1777282091.jpg\" alt=\"Epigenetics Market to Reach $4.29 Billion by 2030, Fueled by Precision Medicine and Next-Gen Sequencing Advancements\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Epigenetics Market by Product &#038; Service (Enzymes, Kits &#038; Reagents (Antibodies), Software), Method (DNA Methylation, Histone Modification), Technique (NGS, PCR), Application (Oncology, Immunology, Developmental Biology), End User &#8211; Global Forecast to 2030<\/div>\n<p style=\"text-align: justify;\"><strong>According to MarketsandMarkets&trade;, <\/strong>the global <strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/epigenetics-technologies-market-896.html?utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Epigenetics Market<\/a><\/strong> is on a strong growth trajectory, projected to expand from <strong>$2.24 billion in 2025 to $4.29 billion by 2030<\/strong>, registering a <strong>CAGR of 13.9%<\/strong>. This growth underscores the increasing strategic importance of epigenetic insights in <strong>precision medicine, drug discovery, and advanced diagnostics<\/strong>.<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure: <a rel=\"nofollow\" name=\"www_marketsandmarkets_com_pdfdownlo\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=896&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=896<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Browse<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>627 <\/strong>Market Data Tables<\/li>\n<li><strong>61 <\/strong>Figures<\/li>\n<li><strong>490 <\/strong>Pages and in-depth TOC on<strong> &#8220;<\/strong> <strong>Epigenetics Market<\/strong> <strong><strong>&#8211; Global Forecast to 2030&rdquo;.<\/strong><\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Rising investments in R&amp;D, coupled with <strong>declining sequencing costs and faster turnaround times<\/strong>, are accelerating adoption across clinical and research environments. At the same time, the expansion of <strong>population-scale screening programs<\/strong> and growing demand for <strong>epigenetic-based therapeutics and diagnostics<\/strong> are reinforcing market momentum.<\/p>\n<p style=\"text-align: justify;\"><strong>Kits &amp; Reagents Segment Anchors Market Leadership<\/strong><\/p>\n<p style=\"text-align: justify;\">The <strong>kits &amp; reagents<\/strong> segment dominated the market in 2024, with antibodies emerging as the most influential sub-segment. Their critical role in <strong>protein detection, gene expression analysis, and cellular regulation monitoring<\/strong> has made them indispensable tools in epigenetic workflows.<\/p>\n<p style=\"text-align: justify;\">As research becomes increasingly data-driven and high-throughput, demand for <strong>reliable, scalable, and application-specific reagents<\/strong> is expected to surge&mdash;positioning this segment as a foundational revenue driver.<\/p>\n<p style=\"text-align: justify;\"><strong>DNA Methylation Maintains Core Role in Epigenetic Research<\/strong><\/p>\n<p style=\"text-align: justify;\">Among methodologies, <strong>DNA methylation<\/strong> accounted for the largest market share in 2024 and continues to be a focal point for innovation&mdash;particularly in oncology.<\/p>\n<p style=\"text-align: justify;\">Its proven utility in <strong>cancer biomarker discovery, disease progression analysis, and therapeutic targeting<\/strong> makes it one of the most commercially and clinically relevant epigenetic approaches. As oncology pipelines expand, DNA methylation-based solutions are expected to remain central to both research and clinical applications.<\/p>\n<p style=\"text-align: justify;\"><strong>Asia Pacific Emerges as High-Growth Strategic Region<\/strong><\/p>\n<p style=\"text-align: justify;\">The <strong>Asia Pacific<\/strong> region is set to record the fastest growth during the forecast period, driven by:<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Rapid improvements in healthcare infrastructure<\/p>\n<\/li>\n<li>\n<p>Increasing R&amp;D investments across emerging economies<\/p>\n<\/li>\n<li>\n<p>Strategic collaborations and global expansion of regional players<\/p>\n<\/li>\n<li>\n<p>Accelerated adoption of advanced technologies such as Next-Generation Sequencing (NGS)<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">These dynamics are transforming Asia Pacific into a <strong>key innovation and outsourcing hub<\/strong> for epigenetics research and development.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages: <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=896&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=896<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Competitive Landscape: Innovation and Integration at the Forefront<\/strong><\/p>\n<p style=\"text-align: justify;\">The market is highly competitive, with leading players focusing on <strong>technology integration, product innovation, and strategic partnerships<\/strong> to strengthen their global presence. Key companies include: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Danaher (US), Active Motif, Inc. (US), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Revvity (US), QIAGEN (Germany), among others.<\/p>\n<p style=\"text-align: justify;\">These players are actively advancing <strong>NGS platforms, epigenetic assays, and bioinformatics solutions<\/strong> to address evolving research and clinical needs.<\/p>\n<p style=\"text-align: justify;\"><strong>Executive Takeaway<\/strong><\/p>\n<p style=\"text-align: justify;\">For industry leaders, the epigenetics market represents a <strong>high-growth, innovation-driven opportunity<\/strong> at the intersection of genomics and precision medicine. Organizations that invest in <strong>scalable technologies, integrated solutions, and global expansion strategies<\/strong> will be best positioned to capture value in this rapidly evolving landscape.<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=613&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Genomics Market<\/a> &#8211; Global Forecast to 2030<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=546&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Next-generation Sequencing Market<\/a> &#8211; Global Forecast to 2031<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=epigenetics-market-to-reach-429-billion-by-2030-fueled-by-precision-medicine-and-nextgen-sequencing-advancements\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/epigenetics-technologies-market-896.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/epigenetics-technologies-market-896.html<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=epigenetics-market-to-reach-429-billion-by-2030-fueled-by-precision-medicine-and-nextgen-sequencing-advancements\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Epigenetics Market by Product &#038; Service (Enzymes, Kits &#038; Reagents (Antibodies), Software), Method (DNA Methylation, Histone Modification), Technique (NGS, PCR), Application (Oncology, Immunology, Developmental Biology), End User &#8211; Global Forecast to 2030 According to MarketsandMarkets&trade;, the global Epigenetics Market is &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/epigenetics-market-to-reach-429-billion-by-2030-fueled-by-precision-medicine-and-nextgen-sequencing-advancements_804800.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,411,404],"tags":[],"class_list":["post-804800","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/804800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=804800"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/804800\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=804800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=804800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=804800"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}